Form 4: Natera Co-Founder Jonathan Sheena Sells Shares Under 10b5-1 Trading Plans

Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on April 3rd and 4th, 2025, under pre-arranged Rule 10b5-1 trading plans.

Summary

• Jonathan Sheena, a co-founder of Natera, Inc., reported the sale of Natera's common stock on April 3rd and 4th, 2025.
• The sales were executed under two Rule 10b5-1 trading plans.
• One plan was adopted on December 11, 2024, and the other on June 7, 2024.
• On April 4, 2025, Sheena sold 1,220 shares at an average price of $132.0414, 1,050 shares at an average price of $133.2752, 400 shares at an average price of $133.86, 300 shares at an average price of $135.2433, and 100 shares at an average price of $136.05.
• On April 3, 2025, Sheena sold shares held by the Caraluna 1 Trust and Caraluna 2 Trust, with prices ranging from $136.88 to $141.29 per share.
• Following these transactions, Sheena directly owns 255,249 shares and indirectly owns 40,282 shares through the Caraluna 2 Trust and 41,542 shares through the Caraluna 1 Trust.

Sentiment

Score: 5

Explanation: The document is neutral as it simply reports stock sales under pre-existing trading plans. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

Sales by insiders are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to sell shares over a period of time, avoiding concerns about trading on non-public information. The market typically analyzes the size and frequency of these sales to gauge insider sentiment.

Comparison to Industry Standards

• It's common for executives at publicly traded companies, including those in the biotech and diagnostics sectors like Natera, to utilize 10b5-1 trading plans.
• Companies like Exact Sciences and Guardant Health also see insider transactions, often through similar pre-planned arrangements.
• The volume and frequency of insider sales are often compared to those of peers to assess whether the activity is typical or indicative of a larger trend or concern.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders if they interpret the sales as a lack of confidence by the co-founder, although the existence of a 10b5-1 plan mitigates this concern.
• The impact on employees, customers, suppliers, and creditors is likely to be minimal, as these transactions do not directly affect the company's operations.

Key Dates

Keywords

Natera, NTRA, Jonathan Sheena, Form 4, Share Sale, 10b5-1 Trading Plan, Caraluna Trust, Insider Trading